Evidence map›Paper›PMID 34443960›Full record

ReviewNanomaterials (Basel, Switzerland)2021

Green Synthesis of Nanomaterials.

Matthew Huston, Melissa DeBella, Maria DiBella, Anisha Gupta

Abstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Food science & nutrition · 2026
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Green Synthesis of Copper Oxide Nanoparticles UsingNanomaterials (Basel, Switzerland) · 2026
    Article
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Matthew HustonInternal Medicine-Infectious Disease, University of Michigan, Ann Arbor, MI 48109, USA.
Melissa DeBellaDepartment of Pharmaceutical Sciences, University of Saint Joseph, Hartford, CT 06117, USA.
Maria DiBellaDepartment of Pharmaceutical Sciences, University of Saint Joseph, Hartford, CT 06117, USA.
Anisha GuptaDepartment of Pharmaceutical Sciences, University of Saint Joseph, Hartford, CT 06117, USA.ORCID 0000-0002-0276-9169

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanotechnology is considered one of the paramount forefronts in science over the last decade. Its versatile implementations and fast-growing demand have paved the way for innovative measures for the synthesis of higher quality nanomaterials. In the early stages, traditional synthesis methods were utilized, and they relied on both carcinogenic chemicals and high energy input for production of nano-sized material. The pollution produced as a result of traditional synthesis methods induces a need for environmentally safer synthesis methods. As the downfalls of climate change become more abundant, the scientific community is persistently seeking solutions to combat the devastation caused by toxic production methods. Green methods for nanomaterial synthesis apply natural biological systems to nanomaterial production. The present review highlights the history of nanoparticle synthesis, starting with traditional methods and progressing towards green methods. Green synthesis is a method just as effective, if not more so, than traditional synthesis; it provides a sustainable approach to nanomaterial manufacturing by using naturally sourced starting materials and relying on low energy processes. The recent use of active molecules in natural biological systems such as bacteria, yeast, algae and fungi report successful results in the synthesis of various nanoparticle systems. Thus, the integration of green synthesis in scientific research and mass production provides a potential solution to the limitations of traditional synthesis methods.

Indexed as

fungigreen synthesisnanomaterialsplantyeast

Identifiers

PMID34443960
PMCPMC8400177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.